PolyPeptide shortlists EQT and IDG Capital as bidding process advances – Private Equity Wire
PolyPeptide Group has narrowed the field of potential buyers for its next auction phase, selecting private equity firms EQT AB and IDG Capital to move forward in the bidding process for the Swiss contract drug manufacturer, according to a report by Bloomberg. The report cites unnamed people familiar with the matter as highlighting that US-based Altaris has also remained engaged…
Key Insights
- This topic is currently trending
- Experts are closely monitoring developments
- It may impact future decisions
